Extension and Amendment Agreement between Entia Biosciences Inc. and Arthur C. Piculell Jr.

Contract Categories: Business Finance › Modification Agreements
Summary

Entia Biosciences Inc., represented by CEO Marvin S. Hausman, and Arthur C. Piculell Jr. have agreed to extend the terms of a previous agreement (Exhibit A) for one year from December 26, 2014, with an 8% interest rate applied from the original note date of August 13, 2013. Additionally, Arthur C. Piculell Jr. will receive a five-year warrant to purchase 50,000 shares at $0.50 per share, with a cashless exchange option. All other terms from the original agreement remain unchanged.

Read More Arrow
EX-10.1 2 ex10-1.htm EX-10.1 ex10-1.htm
Exhibit 10.1
 
 
December 26th, 2014


Arthur C. Piculell Jr. and Marvin S. Hausman, CEO Entia Biosciences Inc. hereby extend Exhibit A attached hereto and made a part hereof as if fully set out herein.
1.  
 This agreement will be extended for one year from the above date with the interest rate of 8% from the original date of note August 13, 2013.
2.  
In addition thereto Arthur C. Piculell Jr. will also receive a 5 year warrant for 50,000 shares with an exercise price of 50 cents.  This warrant shall have a cashless exchange provision.
3.  
All other terms shall remain the same as set forth in Exhibit A.



/s/ Marvin S. Hausman                                                                          Dated:  January 10, 2015
Marvin S. Hausman, CEO Entia Biosciences Inc.




/s/ Arthur C. Piculell Jr.                                                                          Dated:  January 10, 2015
Arthur C. Piculell Jr.